Literature DB >> 3557012

Effects of fasting and chronic alcohol consumption on the first-pass metabolism of ethanol.

C DiPadova, T M Worner, R J Julkunen, C S Lieber.   

Abstract

The present investigation was undertaken to evaluate what fraction of alcohol ingested in amounts during usual "social drinking" does not enter the systemic circulation. To that effect, on consecutive days, either peroral or intravenous ethanol was administered in both fed and fasted states to 7 nonalcoholic and 18 alcoholic subjects. In nonalcoholics consuming 0.15 g/kg body wt ethanol, the magnitude of first-pass metabolism of ethanol was 3.94 +/- 0.15 mmol/L X h, calculated as the difference of the areas under the curve obtained after oral and intravenous alcohol administration. The first-pass metabolism accounted for 73% of the latter. When the administered dose was increased to 0.3 g/kg body wt ethanol, the corresponding values were 6.46 +/- 0.50 mmol/L X h and 44%. Fasting decreased this effect. When alcoholics consumed 0.15 g/kg body wt ethanol, the corresponding values were 0.92 +/- 0.65 mmol/L X h and 23%. When these alcoholics were fasted, the first-pass metabolism again decreased and it was significantly lower than in the nonalcoholics tested under the same conditions. We conclude that in humans a significant fraction of ingested alcohol undergoes first-pass metabolism but that this effect is reduced in alcoholics and by fasting. The magnitude of this process determines the bioavailability of alcohol and thus modulates its potential toxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3557012     DOI: 10.1016/s0016-5085(87)91073-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  Lack of effect of omeprazole, cimetidine, and ranitidine on the pharmacokinetics of ethanol in fasting male volunteers.

Authors:  K A Jönsson; A W Jones; H Boström; T Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity.

Authors:  Krisstonia Spruiell; Afua A Gyamfi; Susan T Yeyeodu; Ricardo M Richardson; Frank J Gonzalez; Maxwell A Gyamfi
Journal:  J Pharmacol Exp Ther       Date:  2015-07-09       Impact factor: 4.030

3.  Cigarette smoking and rate of gastric emptying: effect on alcohol absorption.

Authors:  R D Johnson; M Horowitz; A F Maddox; J M Wishart; D J Shearman
Journal:  BMJ       Date:  1991-01-05

Review 4.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

5.  Effect of omeprazole on gastric first-pass metabolism of ethanol.

Authors:  R Roine; R Hernández-Muñoz; E Baraona; R Greenstein; C S Lieber
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 6.  The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation.

Authors:  Li Di; Amanda Balesano; Samantha Jordan; Sophia M Shi
Journal:  AAPS J       Date:  2021-01-07       Impact factor: 4.009

7.  Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism.

Authors:  A S Brown; J R Fiaterone; C P Day; M K Bennett; P J Kelly; O F James
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

8.  Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999-2018.

Authors:  Young-Hee Yoon; Chiung M Chen; Megan E Slater; M Katherine Jung; Aaron M White
Journal:  Am J Prev Med       Date:  2020-08-27       Impact factor: 5.043

9.  First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying.

Authors:  C M Oneta; U A Simanowski; M Martinez; A Allali-Hassani; X Parés; N Homann; C Conradt; R Waldherr; W Fiehn; C Coutelle; H K Seitz
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

Review 10.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.